How 'traffic' in our cells works both for and against us

Date:

May 1, 2013

Source:

Hebrew University of Jerusalem

Summary:

A mechanism that permits essential substances to enter our cells while at the same time removing from them harmful components also has a “down side.” This negativeaspect prevents vital drugs, such as anti-cancer drugs, from achieving their designed functions, while also enabling bacterial cells to develop resistance to penetration of antibiotics.

Share:

Total shares:

FULL STORY

A mechanism that permits essential substances to enter our cells while at the same time removing from them harmful components also has a "down side." This negativeaspect prevents vital drugs, such as anti-cancer drugs, from achieving their designed functions, while also enabling bacterial cells to develop resistance to penetration of antibiotics.

A study aimed at a fuller understanding of how this selective mechanism works -- with a view towards better controlling it through new drug designs -- is the subject of an article by Hebrew University of Jerusalem and German researchers that. has been published in Proceedings of the National Academy of Sciences in the US (PNAS).

The trafficking of materials in and out of cells is controlled by a variety of proteins found in the membrane surrounding living cells, called "transporters." It is these transporters that fulfill the important function of allowing entrance of vital compounds on the one hand and disposal of toxic compounds on the other hand.

While providing an essential survival strategy for the organism, the transporters that remove toxic compounds from the cell have been associated with the ability of the bacterial cell to develop resistance to antibiotics. In mammalian cells, transporters are responsible for some types of resistance of cancer cells to antineoplastic drugs (drugs against abnormal/cancerous growths). Since this resistance poses serious problems in the treatment of cancers and infectious diseases, these proteins are an important target for drug design.

To progress in this pursuit, a more complete knowledge of the transporter mechanism is required, but despite many studies, this mechanism is not yet fully understood. It is, however, well established that an essential part of the mechanism stems from the ability of the transporter to change conformations. Thus, the binding site of a particular transporter is alternatively exposed either to the cell cytoplasm (interior) or to the outside environment, enabling the protein to bind its materials on one side of the cell and transport them to the other side.

The research conducted by the Hebrew University-German team focused at a model transporter expressed in the brain: VMAT (Vesicular MonoAmine Transporter). VMAT is known to transport a variety of neurotransmitters like adrenaline, dopamine and serotonin. In addition, it can also transport MPP, a neurotoxin involved in models of Parkinson's disease.

A functional and structural link between VMAT and bacterial transporters responsible for multidrug resistance may suggest a common origin for both types of proteins. A number of studies demonstrated the significance of VMAT as a target for drug therapy in a variety of pathologic states, such as high blood pressure, hyperkinetic movement disorders and Tourette syndrome.

The research was conducted by Shimon Schuldiner, the Mathilda Marks-Kennedy Professor of Biochemistry at the Hebrew University, and his research students Dana Yaffe and Yonatan Shuster, in cooperation with a group led by Dr Lucy Forrest at the Max Planck institute in Frankfurt, Germany, and her post-doctoral associate Sebastian Radestock.

A computational method was used, allowing the development of a novel model, simulating the protein's 3D structure. The model led to a series of biochemical experiments, which in turn provided a better understanding of the transporter's conformational changes. Specifically, the research identified interactions within the protein that mediate the conformational changes.

The researchers hope that this knowledge may, in the future, help in designing drugs for treating pathologies involving transporters similar to VMAT, including infectious and neurological diseases.

Hebrew University of Jerusalem. "How 'traffic' in our cells works both for and against us." ScienceDaily. ScienceDaily, 1 May 2013. <www.sciencedaily.com/releases/2013/05/130501090700.htm>.

Hebrew University of Jerusalem. (2013, May 1). How 'traffic' in our cells works both for and against us. ScienceDaily. Retrieved August 2, 2015 from www.sciencedaily.com/releases/2013/05/130501090700.htm

Hebrew University of Jerusalem. "How 'traffic' in our cells works both for and against us." ScienceDaily. www.sciencedaily.com/releases/2013/05/130501090700.htm (accessed August 2, 2015).

July 31, 2015  Resettlement projects in the Amazon are driving severe tropical deforestation, according to new research. Widely hailed as a socially responsible and 'innocuous' strategy of land redistribution, ... read more

July 29, 2015  Viewing aquarium displays led to noticeable reductions in blood pressure and heart rate, a research team found in the first study of its kind. They also noted that higher numbers of fish helped to ... read more

July 31, 2015  A new study examines how consuming the concentrated extract of thylakoids found in spinach can reduce hunger and cravings. Thylakoids encourage the release of satiety hormones, which is very ... read more

July 30, 2015  The behavior of fruit flies, which are commonly used in laboratory experiments, is altered by electric fields, new research shows. The research indicates that the wings of the insects are disturbed ... read more

July 31, 2015  Starvation early in life can alter an organism for generations to come, according to a new study in nematodes. The epigenetic effects are a 'bet-hedging strategy.' Famine survivors are smaller and ... read more

July 31, 2015  The humble butterfly could hold the key to unlocking new techniques to make solar energy cheaper and more efficient, pioneering new research has shown. By mimicking the v-shaped posture adopted by ... read more

June 10, 2015  Many cancer patients survive treatment only to have a recurrence within a few years. Recurrences and tumor spreading are likely due to cancer stem cells that can be tough to kill with conventional ... read more

June 4, 2013  Malaria parasites that develop resistance to the most effective class of anti-malarial drugs may become susceptible to other treatments as a result. The discovery could reveal potential new drug ... read more

Oct. 12, 2011  In an advance toward eliminating pockets of infection in the brain that help make HIV disease incurable, scientists report the development of new substances that first plug the biological vacuum ... read more

Jan. 5, 2011  Genetic resistance to antibiotics is not the only trick bacteria use to resist eradication -- they also have a second defense strategy known as persistence that can kick in. Researchers have now ... read more